These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20687077)

  • 1. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Wheeler DM; Silove N; Hazell P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD004677. PubMed ID: 20687077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD).
    Williams K; Brignell A; Randall M; Silove N; Hazell P
    Cochrane Database Syst Rev; 2013 Aug; (8):CD004677. PubMed ID: 23959778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous secretin for autism spectrum disorders (ASD).
    Williams K; Wray JA; Wheeler DM
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003495. PubMed ID: 22513913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
    Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
    Kolevzon A; Mathewson KA; Hollander E
    J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
    Walitt B; Urrútia G; Nishishinya MB; Cantrell SE; Häuser W
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011735. PubMed ID: 26046493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).
    Soomro GM; Altman D; Rajagopal S; Oakley-Browne M
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD001765. PubMed ID: 18253995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous secretin for autism spectrum disorder.
    Williams KW; Wray JJ; Wheeler DM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003495. PubMed ID: 16034901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine versus other types of pharmacotherapy for depression.
    Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD004185. PubMed ID: 24353997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors for fibromyalgia syndrome.
    Riera R
    Sao Paulo Med J; 2015; 133(5):454. PubMed ID: 26648437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
    Figgitt DP; McClellan KJ
    Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.